Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04333953 · ClinicalTrials.gov registry record
COVID-19 in Patients With HIV
A clinical trial of COVID-19 and HIV/AIDS, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- 412
- Enrollment target
- 1
- Study location
NCT04333953 is a study of COVID-19 and HIV/AIDS that has completed, run by University of Missouri-Columbia. The registered enrollment target is 412 participants, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04333953, a study of COVID-19 and HIV/AIDS, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- 412 participants
- Enrollment target
- 1
- Study location
Study Summary
Currently, limited data is available about patients with HIV in the context of the COVID-19 pandemic. People with HIV who have not achieved viral suppression through antiretroviral treatment may have a compromised immune system that leaves them vulnerable to infections and disease progression. However, little is known about the presentation and clinical outcomes of patients with HIV and SARS-CoV-2. Our aim is to characterize the clinical presentation and disease course of COVID-19 in patients with HIV.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
Missouri
- University of Missouri-Columbia - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 412 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2022-03-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04333953
The ClinicalTrials.gov registry entry for NCT04333953 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 412 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT04333953 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT04333953 about?
NCT04333953 is a clinical study titled "COVID-19 in Patients With HIV". Currently, limited data is available about patients with HIV in the context of the COVID-19 pandemic. People with HIV who have not achieved viral suppression through antiretroviral treatment may have a compromised immune system that leaves them vulnerable to infections and disease progression. Howev...
What is the current status of trial NCT04333953?
This trial is currently completed. The enrollment target is 412 participants. The study started on 2020-04-01. Estimated completion is 2022-03-28.
What conditions does trial NCT04333953 study?
This clinical trial studies the following conditions: COVID-19, HIV/AIDS, SARS-CoV-2.
What interventions are being tested in trial NCT04333953?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04333953?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04333953 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.